A reappraisal of the actions of noradrenaline and 5-hydroxytryptamine on cerebral cortical neurons.
D000200:Action Potentials / Q000187:drug effects; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000758:Anesthesia; D000818:Animals; D002415:Cats; D002540:Cerebral Cortex / Q000187:drug effects*; D003404:Creatinine / Q000378:metabolism; D003655:Decerebrate State; D003983:Dibenzylchlorethamine / Q000494:pharmacology; D004558:Electric Stimulation; D004983:Ethanolamines / Q000494:pharmacology*; D005260:Female; D005971:Glutamates / Q000494:pharmacology; D006863:Hydrogen-Ion Concentration; D008297:Male; D008298:Maleates / Q000494:pharmacology; D009474:Neurons / Q000187:drug effects; D009578:Nitrobenzenes / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology*; D010627:Phenethylamines / Q000494:pharmacology*; D010643:Phenoxybenzamine / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D012701:Serotonin / Q000494:pharmacology*; D013565:Sympatholytics / Q000494:pharmacology
D000319:Adrenergic beta-Antagonists; D004983:Ethanolamines; D005971:Glutamates; D008298:Maleates; D009578:Nitrobenzenes; D010627:Phenethylamines; D013565:Sympatholytics; D010643:Phenoxybenzamine; D012701:Serotonin; D003983:Dibenzylchlorethamine; D003404:Creatinine; D009638:Norepinephrine; D010646:Phentolamine